Serotonin solves decades-old mystery in Parkinson's disease

June 30, 2010
PET image of a healthy brain. Credit: Image courtesy of Marios Politis

Sudden, uncontrolled movements called dyskinesias—a common side effect of treatment for Parkinson’s disease— are a result of excess serotonin cells in transplanted tissue that trick the brain into releasing dopamine, suggests a new study of two Parkinson's disease patients that received fetal tissue transplants over a decade ago, researchers report in the June 30 issue of Science Translational Medicine.

The study sheds light on the long term consequences of brain tissue transplants and may help improve future trials that consist of transplanting cells from other sources, such as bioengineered cells or . Pioneering surgeries performed with aborted fetal tissue in the 1980’s in patients with Parkinson’s proved that the diseased brain could be repaired, at least in some cases. The treatment aimed to replace decayed cells in the brain’s of Parkinson’s patients. Some transplanted patients showed remarkable improvement but eventually the majority developed dyskinesias.

The controversy surrounding the transplantation of fetal into adults put an end to human trials in the United States in the late 1980’s when the U.S. government temporarily banned fetal tissue research, though research continued in other parts of the world. The U.S. ban was lifted in the early 1990’s, but the cause of dyskinesias in these patients remained a mystery, and no effective treatment has been found.

Now, Marios Politis and colleagues in the United Kingdom and Sweden have discovered that the is the culprit. Using imaging scans and radioactive tracers, the researchers were able to visualize the function of different chemicals in the two patient’s brains. Taking a closer look, they found that previously decayed dopamine neurons—a hallmark of Parkinson’s disease—were still restored and fully functional over a decade after transplantation. But Politis and colleagues also saw unexpectedly high amounts of serotonin neurons in the transplanted tissue.

The finding is puzzling because the usual dyskinesias in Parkinson’s are thought to be a result of dopamine action, not serotonin. The researchers discovered that the deceptive ability of serotonin neurons to switch to a different neurotransmitter—to adopt and pump out dopamine—causes the dyskinesias. Administering a drug to block this action almost immediately eliminated the dyskinesias in both patients. The authors also suggest that removing in any future cell-based therapies might prevent this crippling side effect. Recently, a new trial launched under the name TRANSEURO plans to use fetal cell therapy to treat , with the first surgeries planned in 2012.

More information: "Serotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson’s Patients with Neural Transplants," by M. Politis et al. Science Translational Medicine.

Related Stories

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Jul 07, 2010
How can there be an excess of serotonin in Parkinson's? Serotonin is responsible for happiness (among other things) - and a deficiency of the neurotransmitter leads to depression, which is strongly connected to PD itself. In fact, many patients with Parkinson's - more than 50% - are also diagnosed with depression. Wouldn't it make sense if there was less - rather than an excess of - serotonin?
It would be great if you could clear this up for me. Thanks.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.